The Crooked, Rocky Path: How a Discovery Progresses from the Lab to the Clinic

October 11, 2012
11th New Jersey Symposium on Biomaterials Science
Hyatt Regency Hotel2 Albany Street
New Brunswick, NJ 08901
The panel includes:
A. Clarke Atwell, Chief Operating Officer, Lux Biosciences, Inc.
Michael Davitz, Partner, Axinn, Veltrop & Harkrider LLP
Dr. Gene Slowinski, Director of Strategic Alliance Research, the Graduate School of Management of Rutgers University
Vincent Smeraglia, Esq., Office of Technology Transfer & Business Development, UMDNJ

Peter J. Butch of the firm's Intellectual Property department will moderate "The Crooked, Rocky Path: How a Discovery Progresses from the Lab to the Clinic."

Discoveries almost never rocket through development straight to the clinic. Most ideas go back to the drawing board once, if not several times, to overcome problems or shortcomings that emerge. This panel discussion will review examples of such indirect development paths and offer practical advice on how best to implement more efficient development plans.
Click here for more information and to register.